137 related articles for article (PubMed ID: 2510135)
1. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM
Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135
[TBL] [Abstract][Full Text] [Related]
2. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
3. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
4. Effect of encainide on in vivo drug metabolism in the rat.
Svensson CK; Knowlton PW
Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):285-8. PubMed ID: 3110886
[TBL] [Abstract][Full Text] [Related]
5. Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine.
Carrum G; Egan JM; Abernethy DR
Clin Pharmacol Ther; 1986 Aug; 40(2):140-3. PubMed ID: 3731677
[TBL] [Abstract][Full Text] [Related]
6. The effect of diltiazem on the disposition of encainide and its active metabolites.
Kazierad DJ; Lalonde RL; Hoon TJ; Mirvis DM; Bottorff MB
Clin Pharmacol Ther; 1989 Dec; 46(6):668-73. PubMed ID: 2513160
[TBL] [Abstract][Full Text] [Related]
7. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
[TBL] [Abstract][Full Text] [Related]
8. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
9. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
10. Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
Bauer LA; Stenwall M; Horn JR; Davis R; Opheim K; Greene L
Clin Pharmacol Ther; 1986 Aug; 40(2):239-42. PubMed ID: 3731687
[TBL] [Abstract][Full Text] [Related]
11. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
Anadón A; Martinez-Larrañaga MR; Fernandez MC; Diaz MJ; Bringas P
Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
[TBL] [Abstract][Full Text] [Related]
12. Quinidine does not alter antipyrine metabolism.
Bowles SK; Cardozo L; Edwards DJ
J Clin Pharmacol; 1990 Mar; 30(3):267-71. PubMed ID: 2312782
[TBL] [Abstract][Full Text] [Related]
13. Effect of deltamethrin on antipyrine pharmacokinetics and metabolism in rat.
Anadón A; Martinez-Larrañaga MR; Díaz MJ; Bringas P; Fernandez MC
Arch Toxicol; 1991; 65(2):156-9. PubMed ID: 2059156
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of encainide in patients with cirrhosis.
Wensing G; Mönig H; Ohnhaus EE; Hoensch HP
Cardiovasc Drugs Ther; 1991 Aug; 5(4):733-9. PubMed ID: 1909559
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the effects of labetalol, verapamil and diltiazem on antipyrine and indocyanine green clearances.
Rocci ML; Vlasses PH; Lener ME; Fruncillo RA; Sirgo MA
J Clin Pharmacol; 1989 Oct; 29(10):891-5. PubMed ID: 2592580
[TBL] [Abstract][Full Text] [Related]
16. Effect of chloroquine and primaquine on antipyrine metabolism.
Back DJ; Purba HS; Park BK; Ward SA; Orme ML
Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
Adedoyin A; Aarons L; Houston JB
Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
[TBL] [Abstract][Full Text] [Related]
20. Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.
Borcherding SM; Bastian TL; Self TH; Abou-Shala N; LeDuc BW; Lalonde RL
Antimicrob Agents Chemother; 1992 Jul; 36(7):1553-8. PubMed ID: 1510454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]